FB VISION S.p.A.

FB Vision S.p.A. specializes in ophthalmic medical devices, primarily eye care solutions. Their portfolio includes intravenous and topical eye drops (such as Ozodrop IVT 15 and Ozodrop 8 mL), lubricating eye drops (like Lacricomplex 10ml and LUMIXA 3 ml), and sterile ophthalmic ointments (e.g., OPTICOL CROSSLIP 10 ml). Some products are also available in preservative-free formulations, such as AQUORAL LIPO 3ML MUESTRA. These devices are designed for use in eye care applications.

FB Vision S.p.A. is based in Italy, specifically in San Benedetto del Tronto, Ascoli Piceno (AP). The company’s headquarters is located at Via San Giovanni Scafa.

FB Vision S.p.A.’s devices are listed in the EUDAQD database (eudamed), which is the official European Union database for medical devices. This registry is used to track and provide transparency on medical devices authorized under the EU Medical Device Regulation.

FB Vision S.p.A.’s devices are classified under the EU Medical Device Regulation as Class IIb. This classification is determined based on the risk associated with the device’s intended use and design. Class IIb devices require a higher level of scrutiny and conformity assessment compared to lower-risk classes, ensuring they meet stringent safety and performance standards.